4-((3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 1g

(R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate, 98.0%, 5mg

4-Cyclobutyl-4-oxobutyric acid, 97.0%, 1g

Volumetric flasks class A transparent, 500 ml, 19/26, 2 Piece(s)

1H-Indazole-3,6-dicarboxylic acid, 98%, 100mg

1100 ml tamper evident jar PP white RD 110 round

4-isopropylbenzo[d]thiazol-2-amine, 95.0%, 250mg

Phenol, 2-[(diphenylphosphinyl)methyl]-, 97%, 25g

Oxetane-2-carboxylic acid, 95.0%, 500mg

1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate, 95%, 50mg

(R)-1,1'-Binaphthyl-2,2'-disulfonyl Dichloride>98.0%(HPLC)200mg

2-Bromo-4-fluoro-5-methylpyridine, 95.0%, 250mg

Naphthalen-2-yl benzenesulfonate, 98%, 1g